Related Experiment Video
Updated: Feb 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Stable-State Midrange Proadrenomedullin Is Associated With Severe Exacerbations in COPD
Emanuel Citgez1, Maaike Zuur-Telgen2, Job van der Palen3
1Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, The Netherlands; Department of Research Methodology, Measurement, and Data Analysis, University of Twente, Enschede, The Netherlands.
Background:
Elevated levels of midrange proadrenomedullin (MR-proADM) are associated with worse outcome in different diseases, including COPD. The association of stable-state MR-proADM with severe acute exacerbations of COPD (AECOPDs) requiring hospitalization, or with community-acquired pneumonia (CAP) in patients with COPD, has not been studied yet. The aim of this study was to evaluate the association of stable-state MR-proADM with severe AECOPD and CAP in patients with COPD.
Methods:
This study pooled data of 1,285 patients from the Cohort of Mortality and Inflammation in COPD (COMIC) and PRedicting Outcome using systemic Markers In Severe Exacerbations of Chronic Obstructive Pulmonary Disease (PROMISE-COPD) cohort studies. Time until first severe AECOPD was compared between patients with high (≥ 0.87 nmol/L) or low (< 0.87 nmol/L) levels of plasma MR-proADM in stable state as previously defined. For time until first CAP, only COMIC data (n = 795) were available.
Results:
Patients with COPD with high-level stable-state MR-proADM have a significantly higher risk for severe AECOPD compared with those with low-level MR-proADM with a corrected hazard ratio (HR) of 1.30 (95% CI, 1.01-1.68). Patients with high-level stable-state MR-proADM had a significantly higher risk for CAP compared with patients with COPD with low-level MR-proADM in univariate analysis (HR, 1.93; 95% CI, 1.24-3.01), but after correction for age, lung function, and previous AECOPD, the association was no longer significant (corrected HR, 1.10; 95% CI, 0.68-1.80).
Conclusions:
Stable-state high-level MR-proADM in patients with COPD is associated with severe AECOPD but not with CAP.
Insights
Elevated midrange proadrenomedullin (MR-proADM) in stable COPD patients predicts a higher risk of severe acute exacerbations (AECOPDs). However, stable MR-proADM levels do not significantly predict community-acquired pneumonia (CAP) in this population.
Area of Science:
- Pulmonary Medicine
- Biomarkers
- Clinical Research
Background:
- Midrange proadrenomedullin (MR-proADM) is linked to adverse outcomes in various diseases.
- Its association with severe acute exacerbations of COPD (AECOPDs) and community-acquired pneumonia (CAP) in stable COPD patients remains uninvestigated.
Purpose of the Study:
- To investigate the association between stable-state MR-proADM levels and the risk of severe AECOPD and CAP in patients with COPD.
Main Methods:
- Data from 1,285 COPD patients from the COMIC and PROMISE-COPD cohorts were pooled.
- Time to first severe AECOPD was compared between patients with high (≥ 0.87 nmol/L) and low (< 0.87 nmol/L) stable-state MR-proADM levels.
- Time to first CAP was analyzed using COMIC data (n=795).
Main Results:
- High stable-state MR-proADM levels were significantly associated with a higher risk of severe AECOPD (corrected HR, 1.30; 95% CI, 1.01-1.68).
- While high MR-proADM showed a univariate association with CAP risk (HR, 1.93; 95% CI, 1.24-3.01), this was not significant after adjusting for covariates (corrected HR, 1.10; 95% CI, 0.68-1.80).
Conclusions:
- Stable-state high MR-proADM levels in COPD patients are a significant predictor of severe AECOPD.
- Stable-state MR-proADM levels do not appear to be a significant predictor of CAP in COPD patients.
Related Concept Videos
Midrange
Simply put, the midrange is half of the data set’s range. Similar to the mean, the midrange is sensitive to the extreme values and hence the prospective outliers. However, unlike the mean, the midrange is not sensitive to all the values of the data set that lie in the middle. Thus, it is prone to...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Multiple Allele Traits
Global Climate Change
Nuclear Stability
To hold positively charged protons together...

